nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—CA5A—female reproductive system—ovarian cancer	0.00458	0.119	CbGeAlD
Brinzolamide—CA9—female reproductive system—ovarian cancer	0.00268	0.0693	CbGeAlD
Brinzolamide—CA9—testis—ovarian cancer	0.00216	0.0559	CbGeAlD
Brinzolamide—CA5B—gonad—ovarian cancer	0.00199	0.0515	CbGeAlD
Brinzolamide—CA12—female reproductive system—ovarian cancer	0.00198	0.0512	CbGeAlD
Brinzolamide—CA5B—female reproductive system—ovarian cancer	0.00178	0.046	CbGeAlD
Brinzolamide—CA2—embryo—ovarian cancer	0.00168	0.0434	CbGeAlD
Brinzolamide—CA5B—vagina—ovarian cancer	0.00161	0.0416	CbGeAlD
Brinzolamide—CA1—female reproductive system—ovarian cancer	0.00157	0.0406	CbGeAlD
Brinzolamide—CA1—bone marrow—ovarian cancer	0.00148	0.0383	CbGeAlD
Brinzolamide—CA5B—testis—ovarian cancer	0.00143	0.0371	CbGeAlD
Brinzolamide—CA2—epithelium—ovarian cancer	0.00137	0.0354	CbGeAlD
Brinzolamide—CA2—decidua—ovarian cancer	0.00129	0.0335	CbGeAlD
Brinzolamide—Dermatitis—Melphalan—ovarian cancer	0.00126	0.00131	CcSEcCtD
Brinzolamide—Cough—Paclitaxel—ovarian cancer	0.00126	0.00131	CcSEcCtD
Brinzolamide—Asthenia—Vinorelbine—ovarian cancer	0.00125	0.0013	CcSEcCtD
Brinzolamide—Arrhythmia—Docetaxel—ovarian cancer	0.00125	0.0013	CcSEcCtD
Brinzolamide—Abdominal pain upper—Epirubicin—ovarian cancer	0.00125	0.0013	CcSEcCtD
Brinzolamide—Hypertension—Paclitaxel—ovarian cancer	0.00124	0.00129	CcSEcCtD
Brinzolamide—Alopecia—Docetaxel—ovarian cancer	0.00124	0.00129	CcSEcCtD
Brinzolamide—Pruritus—Vinorelbine—ovarian cancer	0.00124	0.00129	CcSEcCtD
Brinzolamide—Breast disorder—Epirubicin—ovarian cancer	0.00123	0.00128	CcSEcCtD
Brinzolamide—Mental disorder—Docetaxel—ovarian cancer	0.00123	0.00128	CcSEcCtD
Brinzolamide—CA4—female reproductive system—ovarian cancer	0.00123	0.0317	CbGeAlD
Brinzolamide—Chest pain—Paclitaxel—ovarian cancer	0.00123	0.00127	CcSEcCtD
Brinzolamide—Arthralgia—Paclitaxel—ovarian cancer	0.00123	0.00127	CcSEcCtD
Brinzolamide—Myalgia—Paclitaxel—ovarian cancer	0.00123	0.00127	CcSEcCtD
Brinzolamide—Nasopharyngitis—Epirubicin—ovarian cancer	0.00122	0.00127	CcSEcCtD
Brinzolamide—Erythema—Docetaxel—ovarian cancer	0.00122	0.00127	CcSEcCtD
Brinzolamide—Malnutrition—Docetaxel—ovarian cancer	0.00122	0.00127	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00122	0.00127	CcSEcCtD
Brinzolamide—Nausea—Topotecan—ovarian cancer	0.00121	0.00126	CcSEcCtD
Brinzolamide—Discomfort—Paclitaxel—ovarian cancer	0.00121	0.00126	CcSEcCtD
Brinzolamide—Dry mouth—Paclitaxel—ovarian cancer	0.0012	0.00125	CcSEcCtD
Brinzolamide—Diarrhoea—Vinorelbine—ovarian cancer	0.00119	0.00124	CcSEcCtD
Brinzolamide—Dysgeusia—Docetaxel—ovarian cancer	0.00119	0.00124	CcSEcCtD
Brinzolamide—Nausea—Melphalan—ovarian cancer	0.00119	0.00124	CcSEcCtD
Brinzolamide—Asthma—Epirubicin—ovarian cancer	0.00118	0.00123	CcSEcCtD
Brinzolamide—Back pain—Docetaxel—ovarian cancer	0.00118	0.00123	CcSEcCtD
Brinzolamide—Muscle spasms—Docetaxel—ovarian cancer	0.00117	0.00122	CcSEcCtD
Brinzolamide—Liver function test abnormal—Doxorubicin—ovarian cancer	0.00117	0.00121	CcSEcCtD
Brinzolamide—Infection—Paclitaxel—ovarian cancer	0.00117	0.00121	CcSEcCtD
Brinzolamide—CA4—bone marrow—ovarian cancer	0.00116	0.03	CbGeAlD
Brinzolamide—Dizziness—Vinorelbine—ovarian cancer	0.00115	0.0012	CcSEcCtD
Brinzolamide—Abdominal pain upper—Doxorubicin—ovarian cancer	0.00115	0.0012	CcSEcCtD
Brinzolamide—Nervous system disorder—Paclitaxel—ovarian cancer	0.00115	0.0012	CcSEcCtD
Brinzolamide—Angina pectoris—Epirubicin—ovarian cancer	0.00115	0.0012	CcSEcCtD
Brinzolamide—Tachycardia—Paclitaxel—ovarian cancer	0.00115	0.00119	CcSEcCtD
Brinzolamide—Breast disorder—Doxorubicin—ovarian cancer	0.00114	0.00119	CcSEcCtD
Brinzolamide—Skin disorder—Paclitaxel—ovarian cancer	0.00114	0.00119	CcSEcCtD
Brinzolamide—Bronchitis—Epirubicin—ovarian cancer	0.00114	0.00118	CcSEcCtD
Brinzolamide—Nasopharyngitis—Doxorubicin—ovarian cancer	0.00113	0.00118	CcSEcCtD
Brinzolamide—CA4—female gonad—ovarian cancer	0.00112	0.0289	CbGeAlD
Brinzolamide—Vomiting—Vinorelbine—ovarian cancer	0.00111	0.00115	CcSEcCtD
Brinzolamide—Rash—Vinorelbine—ovarian cancer	0.0011	0.00115	CcSEcCtD
Brinzolamide—Dermatitis—Vinorelbine—ovarian cancer	0.0011	0.00114	CcSEcCtD
Brinzolamide—Hypotension—Paclitaxel—ovarian cancer	0.0011	0.00114	CcSEcCtD
Brinzolamide—Headache—Vinorelbine—ovarian cancer	0.00109	0.00114	CcSEcCtD
Brinzolamide—Asthma—Doxorubicin—ovarian cancer	0.00109	0.00114	CcSEcCtD
Brinzolamide—Pollakiuria—Epirubicin—ovarian cancer	0.00109	0.00113	CcSEcCtD
Brinzolamide—Palpitations—Docetaxel—ovarian cancer	0.00108	0.00112	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00107	0.00111	CcSEcCtD
Brinzolamide—Cough—Docetaxel—ovarian cancer	0.00106	0.00111	CcSEcCtD
Brinzolamide—Angina pectoris—Doxorubicin—ovarian cancer	0.00106	0.00111	CcSEcCtD
Brinzolamide—Insomnia—Paclitaxel—ovarian cancer	0.00106	0.00111	CcSEcCtD
Brinzolamide—Paraesthesia—Paclitaxel—ovarian cancer	0.00105	0.0011	CcSEcCtD
Brinzolamide—Hypertension—Docetaxel—ovarian cancer	0.00105	0.0011	CcSEcCtD
Brinzolamide—Infestation NOS—Epirubicin—ovarian cancer	0.00105	0.0011	CcSEcCtD
Brinzolamide—Infestation—Epirubicin—ovarian cancer	0.00105	0.0011	CcSEcCtD
Brinzolamide—Bronchitis—Doxorubicin—ovarian cancer	0.00105	0.00109	CcSEcCtD
Brinzolamide—Dyspnoea—Paclitaxel—ovarian cancer	0.00105	0.00109	CcSEcCtD
Brinzolamide—Somnolence—Paclitaxel—ovarian cancer	0.00104	0.00109	CcSEcCtD
Brinzolamide—CA5B—lymph node—ovarian cancer	0.00104	0.0269	CbGeAlD
Brinzolamide—Myalgia—Docetaxel—ovarian cancer	0.00104	0.00108	CcSEcCtD
Brinzolamide—Arthralgia—Docetaxel—ovarian cancer	0.00104	0.00108	CcSEcCtD
Brinzolamide—Chest pain—Docetaxel—ovarian cancer	0.00104	0.00108	CcSEcCtD
Brinzolamide—Nausea—Vinorelbine—ovarian cancer	0.00104	0.00108	CcSEcCtD
Brinzolamide—Dyspepsia—Paclitaxel—ovarian cancer	0.00103	0.00108	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00103	0.00107	CcSEcCtD
Brinzolamide—Conjunctivitis—Epirubicin—ovarian cancer	0.00102	0.00106	CcSEcCtD
Brinzolamide—Decreased appetite—Paclitaxel—ovarian cancer	0.00102	0.00106	CcSEcCtD
Brinzolamide—CA2—female reproductive system—ovarian cancer	0.00102	0.0263	CbGeAlD
Brinzolamide—Dry mouth—Docetaxel—ovarian cancer	0.00102	0.00106	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00101	0.00105	CcSEcCtD
Brinzolamide—Fatigue—Paclitaxel—ovarian cancer	0.00101	0.00105	CcSEcCtD
Brinzolamide—Pollakiuria—Doxorubicin—ovarian cancer	0.00101	0.00105	CcSEcCtD
Brinzolamide—Pain—Paclitaxel—ovarian cancer	0.001	0.00104	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000996	0.00104	CcSEcCtD
Brinzolamide—Epistaxis—Epirubicin—ovarian cancer	0.000993	0.00103	CcSEcCtD
Brinzolamide—CA4—testis—ovarian cancer	0.000989	0.0256	CbGeAlD
Brinzolamide—Infection—Docetaxel—ovarian cancer	0.000989	0.00103	CcSEcCtD
Brinzolamide—Sinusitis—Epirubicin—ovarian cancer	0.000988	0.00103	CcSEcCtD
Brinzolamide—Nervous system disorder—Docetaxel—ovarian cancer	0.000976	0.00102	CcSEcCtD
Brinzolamide—Infestation—Doxorubicin—ovarian cancer	0.000974	0.00101	CcSEcCtD
Brinzolamide—Infestation NOS—Doxorubicin—ovarian cancer	0.000974	0.00101	CcSEcCtD
Brinzolamide—Tachycardia—Docetaxel—ovarian cancer	0.000972	0.00101	CcSEcCtD
Brinzolamide—Feeling abnormal—Paclitaxel—ovarian cancer	0.000968	0.00101	CcSEcCtD
Brinzolamide—Skin disorder—Docetaxel—ovarian cancer	0.000967	0.00101	CcSEcCtD
Brinzolamide—Bradycardia—Epirubicin—ovarian cancer	0.000962	0.001	CcSEcCtD
Brinzolamide—CA2—bone marrow—ovarian cancer	0.00096	0.0248	CbGeAlD
Brinzolamide—Rhinitis—Epirubicin—ovarian cancer	0.000948	0.000986	CcSEcCtD
Brinzolamide—Conjunctivitis—Doxorubicin—ovarian cancer	0.000947	0.000985	CcSEcCtD
Brinzolamide—Hypoaesthesia—Epirubicin—ovarian cancer	0.00094	0.000978	CcSEcCtD
Brinzolamide—Pharyngitis—Epirubicin—ovarian cancer	0.000938	0.000976	CcSEcCtD
Brinzolamide—Urinary tract disorder—Epirubicin—ovarian cancer	0.000933	0.000971	CcSEcCtD
Brinzolamide—Urticaria—Paclitaxel—ovarian cancer	0.000933	0.000971	CcSEcCtD
Brinzolamide—Oedema peripheral—Epirubicin—ovarian cancer	0.000931	0.000969	CcSEcCtD
Brinzolamide—Hypotension—Docetaxel—ovarian cancer	0.00093	0.000968	CcSEcCtD
Brinzolamide—Connective tissue disorder—Epirubicin—ovarian cancer	0.000929	0.000966	CcSEcCtD
Brinzolamide—Urethral disorder—Epirubicin—ovarian cancer	0.000927	0.000964	CcSEcCtD
Brinzolamide—CA2—female gonad—ovarian cancer	0.000925	0.0239	CbGeAlD
Brinzolamide—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000921	0.000958	CcSEcCtD
Brinzolamide—CA2—vagina—ovarian cancer	0.000919	0.0238	CbGeAlD
Brinzolamide—Epistaxis—Doxorubicin—ovarian cancer	0.000919	0.000956	CcSEcCtD
Brinzolamide—CA1—lymph node—ovarian cancer	0.000918	0.0237	CbGeAlD
Brinzolamide—Sinusitis—Doxorubicin—ovarian cancer	0.000914	0.000951	CcSEcCtD
Brinzolamide—Visual impairment—Epirubicin—ovarian cancer	0.000911	0.000948	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000907	0.000944	CcSEcCtD
Brinzolamide—Insomnia—Docetaxel—ovarian cancer	0.0009	0.000937	CcSEcCtD
Brinzolamide—Paraesthesia—Docetaxel—ovarian cancer	0.000894	0.00093	CcSEcCtD
Brinzolamide—Bradycardia—Doxorubicin—ovarian cancer	0.00089	0.000926	CcSEcCtD
Brinzolamide—Dyspnoea—Docetaxel—ovarian cancer	0.000888	0.000923	CcSEcCtD
Brinzolamide—Somnolence—Docetaxel—ovarian cancer	0.000885	0.000921	CcSEcCtD
Brinzolamide—Eye disorder—Epirubicin—ovarian cancer	0.000883	0.000919	CcSEcCtD
Brinzolamide—Tinnitus—Epirubicin—ovarian cancer	0.000881	0.000917	CcSEcCtD
Brinzolamide—Cardiac disorder—Epirubicin—ovarian cancer	0.000877	0.000912	CcSEcCtD
Brinzolamide—Rhinitis—Doxorubicin—ovarian cancer	0.000877	0.000912	CcSEcCtD
Brinzolamide—Dyspepsia—Docetaxel—ovarian cancer	0.000876	0.000912	CcSEcCtD
Brinzolamide—Hypoaesthesia—Doxorubicin—ovarian cancer	0.00087	0.000905	CcSEcCtD
Brinzolamide—Pharyngitis—Doxorubicin—ovarian cancer	0.000868	0.000903	CcSEcCtD
Brinzolamide—Decreased appetite—Docetaxel—ovarian cancer	0.000865	0.0009	CcSEcCtD
Brinzolamide—Hypersensitivity—Paclitaxel—ovarian cancer	0.000865	0.0009	CcSEcCtD
Brinzolamide—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000864	0.000898	CcSEcCtD
Brinzolamide—Oedema peripheral—Doxorubicin—ovarian cancer	0.000862	0.000896	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00086	0.000894	CcSEcCtD
Brinzolamide—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000859	0.000894	CcSEcCtD
Brinzolamide—Fatigue—Docetaxel—ovarian cancer	0.000858	0.000893	CcSEcCtD
Brinzolamide—Angiopathy—Epirubicin—ovarian cancer	0.000858	0.000892	CcSEcCtD
Brinzolamide—Urethral disorder—Doxorubicin—ovarian cancer	0.000857	0.000892	CcSEcCtD
Brinzolamide—Immune system disorder—Epirubicin—ovarian cancer	0.000854	0.000888	CcSEcCtD
Brinzolamide—Mediastinal disorder—Epirubicin—ovarian cancer	0.000852	0.000886	CcSEcCtD
Brinzolamide—Pain—Docetaxel—ovarian cancer	0.000851	0.000886	CcSEcCtD
Brinzolamide—Arrhythmia—Epirubicin—ovarian cancer	0.000844	0.000878	CcSEcCtD
Brinzolamide—Visual impairment—Doxorubicin—ovarian cancer	0.000843	0.000877	CcSEcCtD
Brinzolamide—Asthenia—Paclitaxel—ovarian cancer	0.000843	0.000877	CcSEcCtD
Brinzolamide—Alopecia—Epirubicin—ovarian cancer	0.000835	0.000869	CcSEcCtD
Brinzolamide—Pruritus—Paclitaxel—ovarian cancer	0.000831	0.000864	CcSEcCtD
Brinzolamide—Mental disorder—Epirubicin—ovarian cancer	0.000828	0.000861	CcSEcCtD
Brinzolamide—Malnutrition—Epirubicin—ovarian cancer	0.000823	0.000856	CcSEcCtD
Brinzolamide—Erythema—Epirubicin—ovarian cancer	0.000823	0.000856	CcSEcCtD
Brinzolamide—Feeling abnormal—Docetaxel—ovarian cancer	0.00082	0.000853	CcSEcCtD
Brinzolamide—CA2—testis—ovarian cancer	0.00082	0.0212	CbGeAlD
Brinzolamide—Eye disorder—Doxorubicin—ovarian cancer	0.000817	0.00085	CcSEcCtD
Brinzolamide—Tinnitus—Doxorubicin—ovarian cancer	0.000815	0.000848	CcSEcCtD
Brinzolamide—Cardiac disorder—Doxorubicin—ovarian cancer	0.000812	0.000844	CcSEcCtD
Brinzolamide—Flatulence—Epirubicin—ovarian cancer	0.000811	0.000843	CcSEcCtD
Brinzolamide—Tension—Epirubicin—ovarian cancer	0.000807	0.00084	CcSEcCtD
Brinzolamide—Dysgeusia—Epirubicin—ovarian cancer	0.000806	0.000838	CcSEcCtD
Brinzolamide—Diarrhoea—Paclitaxel—ovarian cancer	0.000804	0.000836	CcSEcCtD
Brinzolamide—Nervousness—Epirubicin—ovarian cancer	0.000799	0.000831	CcSEcCtD
Brinzolamide—Back pain—Epirubicin—ovarian cancer	0.000796	0.000828	CcSEcCtD
Brinzolamide—Angiopathy—Doxorubicin—ovarian cancer	0.000793	0.000825	CcSEcCtD
Brinzolamide—Muscle spasms—Epirubicin—ovarian cancer	0.000791	0.000823	CcSEcCtD
Brinzolamide—Immune system disorder—Doxorubicin—ovarian cancer	0.00079	0.000822	CcSEcCtD
Brinzolamide—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000788	0.00082	CcSEcCtD
Brinzolamide—Arrhythmia—Doxorubicin—ovarian cancer	0.000781	0.000813	CcSEcCtD
Brinzolamide—Dizziness—Paclitaxel—ovarian cancer	0.000777	0.000808	CcSEcCtD
Brinzolamide—Vision blurred—Epirubicin—ovarian cancer	0.000775	0.000807	CcSEcCtD
Brinzolamide—Alopecia—Doxorubicin—ovarian cancer	0.000773	0.000804	CcSEcCtD
Brinzolamide—Mental disorder—Doxorubicin—ovarian cancer	0.000766	0.000797	CcSEcCtD
Brinzolamide—Ill-defined disorder—Epirubicin—ovarian cancer	0.000763	0.000794	CcSEcCtD
Brinzolamide—Malnutrition—Doxorubicin—ovarian cancer	0.000761	0.000792	CcSEcCtD
Brinzolamide—Erythema—Doxorubicin—ovarian cancer	0.000761	0.000792	CcSEcCtD
Brinzolamide—Agitation—Epirubicin—ovarian cancer	0.000756	0.000787	CcSEcCtD
Brinzolamide—Flatulence—Doxorubicin—ovarian cancer	0.00075	0.00078	CcSEcCtD
Brinzolamide—Tension—Doxorubicin—ovarian cancer	0.000747	0.000777	CcSEcCtD
Brinzolamide—Vomiting—Paclitaxel—ovarian cancer	0.000747	0.000777	CcSEcCtD
Brinzolamide—Dysgeusia—Doxorubicin—ovarian cancer	0.000746	0.000776	CcSEcCtD
Brinzolamide—Malaise—Epirubicin—ovarian cancer	0.000742	0.000772	CcSEcCtD
Brinzolamide—Rash—Paclitaxel—ovarian cancer	0.000741	0.00077	CcSEcCtD
Brinzolamide—Dermatitis—Paclitaxel—ovarian cancer	0.00074	0.00077	CcSEcCtD
Brinzolamide—Nervousness—Doxorubicin—ovarian cancer	0.000739	0.000769	CcSEcCtD
Brinzolamide—Vertigo—Epirubicin—ovarian cancer	0.000739	0.000769	CcSEcCtD
Brinzolamide—Back pain—Doxorubicin—ovarian cancer	0.000736	0.000766	CcSEcCtD
Brinzolamide—Headache—Paclitaxel—ovarian cancer	0.000736	0.000765	CcSEcCtD
Brinzolamide—Hypersensitivity—Docetaxel—ovarian cancer	0.000734	0.000763	CcSEcCtD
Brinzolamide—Muscle spasms—Doxorubicin—ovarian cancer	0.000732	0.000761	CcSEcCtD
Brinzolamide—Palpitations—Epirubicin—ovarian cancer	0.000727	0.000756	CcSEcCtD
Brinzolamide—Cough—Epirubicin—ovarian cancer	0.000718	0.000747	CcSEcCtD
Brinzolamide—Vision blurred—Doxorubicin—ovarian cancer	0.000718	0.000746	CcSEcCtD
Brinzolamide—CA4—lymph node—ovarian cancer	0.000717	0.0186	CbGeAlD
Brinzolamide—Asthenia—Docetaxel—ovarian cancer	0.000714	0.000743	CcSEcCtD
Brinzolamide—Hypertension—Epirubicin—ovarian cancer	0.00071	0.000739	CcSEcCtD
Brinzolamide—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000706	0.000735	CcSEcCtD
Brinzolamide—Pruritus—Docetaxel—ovarian cancer	0.000704	0.000733	CcSEcCtD
Brinzolamide—Chest pain—Epirubicin—ovarian cancer	0.000701	0.000729	CcSEcCtD
Brinzolamide—Arthralgia—Epirubicin—ovarian cancer	0.000701	0.000729	CcSEcCtD
Brinzolamide—Myalgia—Epirubicin—ovarian cancer	0.000701	0.000729	CcSEcCtD
Brinzolamide—Agitation—Doxorubicin—ovarian cancer	0.0007	0.000728	CcSEcCtD
Brinzolamide—Nausea—Paclitaxel—ovarian cancer	0.000698	0.000726	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000696	0.000724	CcSEcCtD
Brinzolamide—Discomfort—Epirubicin—ovarian cancer	0.000692	0.00072	CcSEcCtD
Brinzolamide—Malaise—Doxorubicin—ovarian cancer	0.000687	0.000714	CcSEcCtD
Brinzolamide—Dry mouth—Epirubicin—ovarian cancer	0.000685	0.000713	CcSEcCtD
Brinzolamide—Vertigo—Doxorubicin—ovarian cancer	0.000684	0.000712	CcSEcCtD
Brinzolamide—Diarrhoea—Docetaxel—ovarian cancer	0.000681	0.000709	CcSEcCtD
Brinzolamide—Palpitations—Doxorubicin—ovarian cancer	0.000673	0.0007	CcSEcCtD
Brinzolamide—Infection—Epirubicin—ovarian cancer	0.000667	0.000694	CcSEcCtD
Brinzolamide—Cough—Doxorubicin—ovarian cancer	0.000664	0.000691	CcSEcCtD
Brinzolamide—Nervous system disorder—Epirubicin—ovarian cancer	0.000659	0.000685	CcSEcCtD
Brinzolamide—Dizziness—Docetaxel—ovarian cancer	0.000658	0.000685	CcSEcCtD
Brinzolamide—Hypertension—Doxorubicin—ovarian cancer	0.000657	0.000684	CcSEcCtD
Brinzolamide—CYP3A4—female reproductive system—ovarian cancer	0.000656	0.017	CbGeAlD
Brinzolamide—Tachycardia—Epirubicin—ovarian cancer	0.000655	0.000682	CcSEcCtD
Brinzolamide—Skin disorder—Epirubicin—ovarian cancer	0.000652	0.000678	CcSEcCtD
Brinzolamide—Chest pain—Doxorubicin—ovarian cancer	0.000648	0.000674	CcSEcCtD
Brinzolamide—Arthralgia—Doxorubicin—ovarian cancer	0.000648	0.000674	CcSEcCtD
Brinzolamide—Myalgia—Doxorubicin—ovarian cancer	0.000648	0.000674	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000644	0.00067	CcSEcCtD
Brinzolamide—Discomfort—Doxorubicin—ovarian cancer	0.00064	0.000666	CcSEcCtD
Brinzolamide—Dry mouth—Doxorubicin—ovarian cancer	0.000634	0.000659	CcSEcCtD
Brinzolamide—Vomiting—Docetaxel—ovarian cancer	0.000633	0.000658	CcSEcCtD
Brinzolamide—Rash—Docetaxel—ovarian cancer	0.000628	0.000653	CcSEcCtD
Brinzolamide—Hypotension—Epirubicin—ovarian cancer	0.000627	0.000653	CcSEcCtD
Brinzolamide—Dermatitis—Docetaxel—ovarian cancer	0.000627	0.000652	CcSEcCtD
Brinzolamide—Headache—Docetaxel—ovarian cancer	0.000624	0.000649	CcSEcCtD
Brinzolamide—Infection—Doxorubicin—ovarian cancer	0.000617	0.000642	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000612	0.000636	CcSEcCtD
Brinzolamide—Nervous system disorder—Doxorubicin—ovarian cancer	0.000609	0.000634	CcSEcCtD
Brinzolamide—Insomnia—Epirubicin—ovarian cancer	0.000607	0.000632	CcSEcCtD
Brinzolamide—Tachycardia—Doxorubicin—ovarian cancer	0.000606	0.000631	CcSEcCtD
Brinzolamide—Skin disorder—Doxorubicin—ovarian cancer	0.000604	0.000628	CcSEcCtD
Brinzolamide—Paraesthesia—Epirubicin—ovarian cancer	0.000603	0.000627	CcSEcCtD
Brinzolamide—Dyspnoea—Epirubicin—ovarian cancer	0.000599	0.000623	CcSEcCtD
Brinzolamide—Somnolence—Epirubicin—ovarian cancer	0.000597	0.000621	CcSEcCtD
Brinzolamide—CA2—lymph node—ovarian cancer	0.000595	0.0154	CbGeAlD
Brinzolamide—Nausea—Docetaxel—ovarian cancer	0.000591	0.000615	CcSEcCtD
Brinzolamide—Dyspepsia—Epirubicin—ovarian cancer	0.000591	0.000615	CcSEcCtD
Brinzolamide—Decreased appetite—Epirubicin—ovarian cancer	0.000584	0.000607	CcSEcCtD
Brinzolamide—Hypotension—Doxorubicin—ovarian cancer	0.000581	0.000604	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.00058	0.000603	CcSEcCtD
Brinzolamide—Fatigue—Epirubicin—ovarian cancer	0.000579	0.000602	CcSEcCtD
Brinzolamide—Pain—Epirubicin—ovarian cancer	0.000574	0.000597	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000566	0.000589	CcSEcCtD
Brinzolamide—Insomnia—Doxorubicin—ovarian cancer	0.000562	0.000585	CcSEcCtD
Brinzolamide—Paraesthesia—Doxorubicin—ovarian cancer	0.000558	0.00058	CcSEcCtD
Brinzolamide—Dyspnoea—Doxorubicin—ovarian cancer	0.000554	0.000576	CcSEcCtD
Brinzolamide—Feeling abnormal—Epirubicin—ovarian cancer	0.000553	0.000576	CcSEcCtD
Brinzolamide—Somnolence—Doxorubicin—ovarian cancer	0.000552	0.000575	CcSEcCtD
Brinzolamide—Dyspepsia—Doxorubicin—ovarian cancer	0.000547	0.000569	CcSEcCtD
Brinzolamide—Decreased appetite—Doxorubicin—ovarian cancer	0.00054	0.000562	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000536	0.000558	CcSEcCtD
Brinzolamide—Fatigue—Doxorubicin—ovarian cancer	0.000536	0.000557	CcSEcCtD
Brinzolamide—Urticaria—Epirubicin—ovarian cancer	0.000533	0.000555	CcSEcCtD
Brinzolamide—Pain—Doxorubicin—ovarian cancer	0.000531	0.000553	CcSEcCtD
Brinzolamide—Feeling abnormal—Doxorubicin—ovarian cancer	0.000512	0.000533	CcSEcCtD
Brinzolamide—Hypersensitivity—Epirubicin—ovarian cancer	0.000495	0.000515	CcSEcCtD
Brinzolamide—Urticaria—Doxorubicin—ovarian cancer	0.000494	0.000513	CcSEcCtD
Brinzolamide—Asthenia—Epirubicin—ovarian cancer	0.000482	0.000501	CcSEcCtD
Brinzolamide—Pruritus—Epirubicin—ovarian cancer	0.000475	0.000494	CcSEcCtD
Brinzolamide—Diarrhoea—Epirubicin—ovarian cancer	0.000459	0.000478	CcSEcCtD
Brinzolamide—Hypersensitivity—Doxorubicin—ovarian cancer	0.000458	0.000476	CcSEcCtD
Brinzolamide—Asthenia—Doxorubicin—ovarian cancer	0.000446	0.000464	CcSEcCtD
Brinzolamide—Dizziness—Epirubicin—ovarian cancer	0.000444	0.000462	CcSEcCtD
Brinzolamide—Pruritus—Doxorubicin—ovarian cancer	0.00044	0.000457	CcSEcCtD
Brinzolamide—Vomiting—Epirubicin—ovarian cancer	0.000427	0.000444	CcSEcCtD
Brinzolamide—Diarrhoea—Doxorubicin—ovarian cancer	0.000425	0.000442	CcSEcCtD
Brinzolamide—Rash—Epirubicin—ovarian cancer	0.000423	0.00044	CcSEcCtD
Brinzolamide—Dermatitis—Epirubicin—ovarian cancer	0.000423	0.00044	CcSEcCtD
Brinzolamide—Headache—Epirubicin—ovarian cancer	0.000421	0.000438	CcSEcCtD
Brinzolamide—Dizziness—Doxorubicin—ovarian cancer	0.000411	0.000427	CcSEcCtD
Brinzolamide—Nausea—Epirubicin—ovarian cancer	0.000399	0.000415	CcSEcCtD
Brinzolamide—Vomiting—Doxorubicin—ovarian cancer	0.000395	0.000411	CcSEcCtD
Brinzolamide—Rash—Doxorubicin—ovarian cancer	0.000392	0.000408	CcSEcCtD
Brinzolamide—Dermatitis—Doxorubicin—ovarian cancer	0.000391	0.000407	CcSEcCtD
Brinzolamide—Headache—Doxorubicin—ovarian cancer	0.000389	0.000405	CcSEcCtD
Brinzolamide—Nausea—Doxorubicin—ovarian cancer	0.000369	0.000384	CcSEcCtD
